國立虎尾科技大學 |

Natural Antimicrobial Agents

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Natural Antimicrobial Agents/ edited by Jean-Michel Mérillon, Céline Riviere.
其他作者:	Mérillon, Jean-Michel.
面頁冊數:	XI, 337 p. 50 illus., 13 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Plant science. -
電子資源:	https://doi.org/10.1007/978-3-319-67045-4
ISBN:	9783319670454

Natural Antimicrobial Agents
Natural Antimicrobial Agents[electronic resource] /edited by Jean-Michel Mérillon, Céline Riviere. - 1st ed. 2018. - XI, 337 p. 50 illus., 13 illus. in color.online resource. - Sustainable Development and Biodiversity,192352-474X ;. - Sustainable Development and Biodiversity,5.

Part I. Plants as source of antibacterials -- 1. New antimicrobials and resistance modifying agents -- 2. Anti-staphylococcal plant natural products -- 3. Natural products in the fight against gram-negative bacteria -- 4. Multidrug resistance Mycobacterium and natural products -- Part II. Natural occurring antifungal natural products -- 5. Antifungal natural products from marine sources -- 6. Antifungal activities of essential oils from Himalayan plants -- 7. Antifungal activity of Citrus essential oils -- 8. Antifungal compounds from Lactobacillus Part III. Antiparasitic natural products -- 9. Antiplasmodial natural products -- 10. Antitrypanosomal natural products -- 11. Antileishmanial natural products -- 12. Anthelmintic natural products -- Part IV. Antiviral natural products -- 13. Anti-HIV natural products -- 14. Natural products and hepatitis C -- 15. Natural stilbenoids from grapevine against HIV-1 Integrase -- 16. Antiviral products from marine sources.

Documenting the latest research in the field of different pathogenic organisms, this book presents the current scenario about promising antimicrobials in the following areas: Part I. Plants as source of antibacterials, Part II. Naturally occurring antifungal natural products, Part III. Antiparasitic natural products, Part IV. Antiviral natural products. Renowned scientists from the globe have been selected as authors to contribute chapters. Use of plants for various ailments is as old as human civilization and continuous efforts are being made to improve medicinal plants or to product their bioactive secondary metabolites in high amounts through various technologies. About 200,000 natural products of plant origin are known and many more are being identified from higher plants and micro-organisms. Some plants based drugs are used since centuries and there is no alternative medicine for many such drugs as cardiac glycosides. Drug discovery from medicinal plants or marine micro-organisms continues to provide an important source of new drug leads. Research on new antibacterials represents a real and timely challenge of this century, particularly for the treatment of infections caused by clinical isolates that show multidrug resistance. The main microorganisms involved in the resistance process have been identified and given the acronym ESKAPE for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacteriaceae. Multidrug resistant Mycobacterium tuberculosis including highly drug-resistant strains (XDR-TB) has also emerged as one of the most important clinical challenges of this century. Plants of diverse taxa and marine micro-organisms are rich source of these antimicrobials. An attempt has been made to compile the recent information about natural sources of antibacterials and their sustainable utilization. Increased panic of these pathogens warrants a growing demand for research to undertake the threat of multidrug resistance. The search for new antifungal, antiparasitic and antiviral natural products is far from devoid of interest. According to the WHO report in 2013, malaria still represents some 207 million cases worldwide and more than 3 billion of people are still exposed to this risk. Similarly, about 350 million people are considered at risk of contracting leishmaniasis. The fight against some viruses also requires that the research on natural products continue. For example, even if an antiretroviral with direct action was recently approved in Europe in 2013, its high cost does not allow to offer it to an exposed population in countries where the cost of drugs remains a problem for a large part of the population. These books are useful to researchers and students in microbiology, biotechnology, pharmacology, chemistry and biology as well as medical professionals.

ISBN: 9783319670454

Standard No.: 10.1007/978-3-319-67045-4doiSubjects--Topical Terms:

1249732
Plant science.

LC Class. No.: QK1-989

Dewey Class. No.: 580

Natural Antimicrobial Agents
LDR:05306nam a22004095i 4500 001 995876
003 DE-He213
005 20200703130323.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319670454 $9 978-3-319-67045-4
024 7 $a 10.1007/978-3-319-67045-4 $2 doi
035 $a 978-3-319-67045-4
050 4 $a QK1-989
072 7 $a PST $2 bicssc
072 7 $a SCI011000 $2 bisacsh
072 7 $a PST $2 thema
082 0 4 $a 580 $2 23
245 1 0 $a Natural Antimicrobial Agents $h [electronic resource] / $c edited by Jean-Michel Mérillon, Céline Riviere.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XI, 337 p. 50 illus., 13 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Sustainable Development and Biodiversity, $x 2352-474X ; $v 19
505 0 $a Part I. Plants as source of antibacterials -- 1. New antimicrobials and resistance modifying agents -- 2. Anti-staphylococcal plant natural products -- 3. Natural products in the fight against gram-negative bacteria -- 4. Multidrug resistance Mycobacterium and natural products -- Part II. Natural occurring antifungal natural products -- 5. Antifungal natural products from marine sources -- 6. Antifungal activities of essential oils from Himalayan plants -- 7. Antifungal activity of Citrus essential oils -- 8. Antifungal compounds from Lactobacillus Part III. Antiparasitic natural products -- 9. Antiplasmodial natural products -- 10. Antitrypanosomal natural products -- 11. Antileishmanial natural products -- 12. Anthelmintic natural products -- Part IV. Antiviral natural products -- 13. Anti-HIV natural products -- 14. Natural products and hepatitis C -- 15. Natural stilbenoids from grapevine against HIV-1 Integrase -- 16. Antiviral products from marine sources.
520 $a Documenting the latest research in the field of different pathogenic organisms, this book presents the current scenario about promising antimicrobials in the following areas: Part I. Plants as source of antibacterials, Part II. Naturally occurring antifungal natural products, Part III. Antiparasitic natural products, Part IV. Antiviral natural products. Renowned scientists from the globe have been selected as authors to contribute chapters. Use of plants for various ailments is as old as human civilization and continuous efforts are being made to improve medicinal plants or to product their bioactive secondary metabolites in high amounts through various technologies. About 200,000 natural products of plant origin are known and many more are being identified from higher plants and micro-organisms. Some plants based drugs are used since centuries and there is no alternative medicine for many such drugs as cardiac glycosides. Drug discovery from medicinal plants or marine micro-organisms continues to provide an important source of new drug leads. Research on new antibacterials represents a real and timely challenge of this century, particularly for the treatment of infections caused by clinical isolates that show multidrug resistance. The main microorganisms involved in the resistance process have been identified and given the acronym ESKAPE for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacteriaceae. Multidrug resistant Mycobacterium tuberculosis including highly drug-resistant strains (XDR-TB) has also emerged as one of the most important clinical challenges of this century. Plants of diverse taxa and marine micro-organisms are rich source of these antimicrobials. An attempt has been made to compile the recent information about natural sources of antibacterials and their sustainable utilization. Increased panic of these pathogens warrants a growing demand for research to undertake the threat of multidrug resistance. The search for new antifungal, antiparasitic and antiviral natural products is far from devoid of interest. According to the WHO report in 2013, malaria still represents some 207 million cases worldwide and more than 3 billion of people are still exposed to this risk. Similarly, about 350 million people are considered at risk of contracting leishmaniasis. The fight against some viruses also requires that the research on natural products continue. For example, even if an antiretroviral with direct action was recently approved in Europe in 2013, its high cost does not allow to offer it to an exposed population in countries where the cost of drugs remains a problem for a large part of the population. These books are useful to researchers and students in microbiology, biotechnology, pharmacology, chemistry and biology as well as medical professionals.
650 0 $a Plant science. $3 1249732
650 0 $a Botany. $3 599558
650 0 $a Biodiversity. $3 593899
650 0 $a Bacteriology. $3 668505
650 0 $a Medicinal chemistry. $3 1253747
650 1 4 $a Plant Sciences. $3 593902
650 2 4 $a Medicinal Chemistry. $3 668872
700 1 $a Mérillon, Jean-Michel. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1262357
700 1 $a Riviere, Céline. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1286974
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319670430
776 0 8 $i Printed edition: $z 9783319670447
776 0 8 $i Printed edition: $z 9783030097868
830 0 $a Sustainable Development and Biodiversity, $x 2352-474X ; $v 5 $3 1253628
856 4 0 $u https://doi.org/10.1007/978-3-319-67045-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)